| Título: | Conjunctivitis in COVID-19 patients: frequency and clinical presentation |
| Autores: | Güemes Villahoz, Noemi ; Burgos Blasco, Bárbara ; García Feijoo, Julián ; Sáenz Francés, Federico ; Arriola Villalobos, Pedro ; Martínez de la Casa, Jose Maria ; Benítez del Castillo, José Manuel ; Herrera de la Muela, María |
| Tipo de documento: | texto impreso |
| Editorial: | Springer, 2020-08-29 |
| Dimensiones: | application/pdf |
| Nota general: | info:eu-repo/semantics/restrictedAccess |
| Idiomas: | |
| Palabras clave: | Estado = Publicado , Materia = Ciencias Biomédicas: Medicina: Enfermedades infecciosas , Materia = Ciencias Biomédicas: Medicina: Oftalmología , Tipo = Artículo |
| Resumen: |
Purpose: The purpose of this study was to evaluate the frequency and clinical presentation of conjunctivitis in hospitalized patients with COVID-19. Methods: A cross-sectional study was conducted at the Hospital Clinico San Carlos of Madrid, Spain. A total of 301 subjects from the COVID admission unit with laboratory-confirmed SARS-CoV-2 infection were included. The presence and clinical characteristics of conjunctivitis were evaluated. Laboratory, radiological, and clinical results in patients with and without conjunctivitis stratified by sex were analyzed. Results: Of the 301 subjects included, 180 patients (59.8%) were male and the median age was 72 years (IQ 59–82). Overall, 35 patients (11.6%) were diagnosed with acute conjunctivitis. We found no relationship between the COVID-19 severity score and the presence of conjunctivitis (P?=?0.17). However, conjunctivitis was more frequent in males with moderate clinical severity and in women classified as clinically mild. The natural history of the disease seems to be a rapid self-limited conjunctivitis that improves without treatment and does not affect visual acuity nor associate short-term complications. Conclusions: Approximately, 1 out of 10 hospitalized non-critical COVID-19 patients presents conjunctivitis during the disease. Compared with other viral conjunctivitis, we found distinctive clinical findings that could guide defining and differentiating conjunctivitis in COVID-19 patients. |
| En línea: | https://eprints.ucm.es/id/eprint/62028/1/Martinez%20de%20la%20Casa_2020_G%C3%BCemes-Villahoz2020_Article_ConjunctivitisInCOVID-19Patien.pdf |
Ejemplares
| Estado |
|---|
| ningún ejemplar |
